Long-term follow-up of cytogenetically normal CEBPA-mutated AML

BACKGROUND: The aim of this study was to analyze the long-term survival of AML patients with CEBPA mutations. PATIENTS AND METHODS: We investigated 88 AML patients with a median age of 61 years and (1) cytogenetically normal AML (CN-AML), (2) monoallelic (moCEBPA) or biallelic (biCEBPA) CEBPA mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastore, Friederike, Kling, Daniela, Hoster, Eva, Dufour, Annika, Konstandin, Nikola P, Schneider, Stephanie, Sauerland, Maria C, Berdel, Wolfgang E, Buechner, Thomas, Woermann, Bernhard, Braess, Jan, Hiddemann, Wolfgang, Spiekermann, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172831/
https://www.ncbi.nlm.nih.gov/pubmed/25214041
http://dx.doi.org/10.1186/s13045-014-0055-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172831/
https://www.ncbi.nlm.nih.gov/pubmed/25214041
http://dx.doi.org/10.1186/s13045-014-0055-7

Ejemplares similares